Join        Login             Stock Quote

Insiders Bought Mead Johnson Nutrition Company (MJN), Should You?

 November 06, 2012 09:48 AM

(By Rich Bieglmeier) Super-storm Sandy closed the market last Monday and Tuesday. As a result, the number of insider transactions last week was limited; however, some purchases of note were on the shortened week's ledger. Investors who use insider buying to create a list of potential ideas could consider names such as Air Products & Chemicals Inc. (APD), Callaway Golf Co. (ELY), Gevo, Inc. (GEVO), Exact Sciences Corporation (EXAS), and Streamline Health Solutions, Inc. (STRM). All of them caught iStock's attention with multiple purchases or dollar amount.

[Related -Mead Johnson Q4 Profit, Sales Top Estimate, Shares Up]

For this column, Mead Johnson Nutrition Company (MJN) will be our focus. Last week, CFO, Peter Leemputte purchased 3,000 shares at $63.61 for a total investment of $190,819. Director James Cornelius wrote a check for $617,515 to buy 10,000 shares at $61.75.

[Related -Mead Johnson (NYSE:MJN): 'Fear Of The Dragon' - Downgrading To Sector Perform - RBC]

In the past two years, Cornelius made four other purchases. In March or 2011, he bought 10,000 shares at $59.91, another 10,000 at $66.43 in May 2011, 10,000 more in August 2011 at $66.71, and 10,000 more in May 2012 at $81.02. Of the four buys, the director exhibited good timing as the stock climbed to more than $75 following his 2011 buys.

The CFO, on the other hand, has done nothing but exercise options and sell MJN stock in the past 24 months. The number cruncher's buy is more potent in our opinion. After all, who knows a company's finances better than the chief financial officer?

The pair of buys comes on the heels of the stock sinking following from $69.51 to $63.53 following earnings on October 25, 2012. Mead Johnson told the conference call attendees that problems in China while getting better, will lead to a sluggish fourth quarter. Apparently, Leemputte and Cornelius believe the street's reaction was overblown.

iStock thinks investors might be wise to wait before joining forces with the director and CFO. The recent snapback gobbled up 50% of the post-eps selloff. The move is a typical retracement following a big drop. It's been our experience that a test of the low will come before a full recovery takes place.

Overall, we feel Mead Johnson Nutrition Company (MJN) will likely have to work through its China issue during the fourth quarter for Wall Street to become believers again. Fundamentally, iStock feels MJN could still be overvalued with a forward P/E of $19.44 while analysts call for 11.2% eps growth in 2013. And that's if bloated 3rd quarter inventory doesn't put additional pressure on margins and shrink profits.

With that in mind, shareholders might think about writing covered calls now, or a bullish spread if shares flirt with $62.  Traders buy and sell call options with the same expiration month to execute a bullish option spread. For example, buying the January 2013 60 call and selling the January 13 65 call. In our view, the spread trade would be a safer way to follow MJN insider's lead.



Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageAutomating Ourselves To Unemployment

In this current era of central planning, malincentives abound. We raced to frack as fast we could for the read on...

article imageFed: Waiting For June… Or Godot?

The Federal Reserve left interest rates unchanged yesterday, as widely expected. But the possibility of a read on...

article imageThe Single Best Place To Invest Your Money For Retirement

It was never supposed to be this daunting. At least that's what we were read on...

article imageNegative Blowback From Negative Interest Rates

The Federal Reserve is widely expected to leave interest rates unchanged today. But perhaps standing pat read on...

Popular Articles

Daily Sector Scan
Partner Center

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.